Targeting Cancer with CRISPR/Cas9-Based Therapy
Cancer is a devastating condition characterised by the uncontrolled division of cells with many forms remaining resistant to current treatment. A hallmark of cancer is the gradual accumulation of somatic mutations which drive tumorigenesis in cancerous cells, creating a mutation landscape distinctiv...
Main Authors: | Katarzyna Balon, Adam Sheriff, Joanna Jacków, Łukasz Łaczmański |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/1/573 |
Similar Items
-
Target search in the CRISPR/Cas9 system: facilitated diffusion with target cues
by: Qiao Lu (路桥), et al.
Published: (2024-01-01) -
Off-target effects in CRISPR/Cas9 gene editing
by: Congting Guo, et al.
Published: (2023-03-01) -
Gene editing and therapy – A new tool: CRISPR/Cas9
by: Ashok M. Patil
Published: (2019-07-01) -
Research Progress on Nanoparticles-Based CRISPR/Cas9 System for Targeted Therapy of Tumors
by: Dengyun Nie, et al.
Published: (2022-09-01) -
Targeting Telomeres and Telomerase: Studies in Aging and Disease Utilizing CRISPR/Cas9 Technology
by: Andrew C. Brane, et al.
Published: (2019-02-01)